Adult bronchiolitis. Evaluation by bronchoalveolar lavage and responses to prednisone therapy

P. M. Dorinsky, W. B. Davis, J. G. Lucas, J. E. Weiland, J. E. Gadek

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Four adult patients with biopsy-proven bronchiolitis were identified and prospectively evaluated. Each patient presented with the rapid onset (weeks to months) of severe respiratory disease that was clinically distinct from asthma, chronic bronchitis, bronchiectasis, cystic fibrosis, and emphysema. Bronchiolitis patients were evaluated by pulmonary function testing and bronchoalveolar lavage (BAL) before and after two months of treatment with 1 mg/kg/day of prednisone. Inital BAL results of bronchiolitis patients were compared to those of cigarette smokers with chronic bronchitis (n=4), asymptomatic cigarette smokers (n=5), and normal nonsmoking volunteers (n=5). Neutrophils comprised 53 ± 13 percent of the cells recovered by BAL in bronchiolitis patients but only 3 ± 2 percent of the cells in chronic bronchitis patients, 1.5 ± 0.6 percent of the cells in asymptomatic smokers, and 0.3 ± 0.3 percent of the cells in normal volunteers (p < 0.01, all comparisons). Moreover, prednisone produced a striking decrease in lower respiratory tract neutrophils (53 ± 13 percent to 8 ± 3 percent, p < 0.05) in all bronchiolitis patients while lung function either improved (two patients) or remained unchanged (two patients). These findings suggest a central role for the neutrophil in bronchiolitis and argue that BAL may be clinically useful in the diagnosis and management of these patients.

Original languageEnglish (US)
Pages (from-to)58-63
Number of pages6
JournalChest
Volume88
Issue number1
DOIs
StatePublished - Jan 1 1985

Fingerprint

Bronchiolitis
Bronchoalveolar Lavage
Prednisone
Chronic Bronchitis
Therapeutics
Neutrophils
Tobacco Products
Healthy Volunteers
Lung
Bronchiectasis
Emphysema
Cystic Fibrosis
Respiratory System
Asthma
Biopsy

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

Adult bronchiolitis. Evaluation by bronchoalveolar lavage and responses to prednisone therapy. / Dorinsky, P. M.; Davis, W. B.; Lucas, J. G.; Weiland, J. E.; Gadek, J. E.

In: Chest, Vol. 88, No. 1, 01.01.1985, p. 58-63.

Research output: Contribution to journalArticle

Dorinsky, P. M. ; Davis, W. B. ; Lucas, J. G. ; Weiland, J. E. ; Gadek, J. E. / Adult bronchiolitis. Evaluation by bronchoalveolar lavage and responses to prednisone therapy. In: Chest. 1985 ; Vol. 88, No. 1. pp. 58-63.
@article{1e357714465f4927ba8fa922c58eece3,
title = "Adult bronchiolitis. Evaluation by bronchoalveolar lavage and responses to prednisone therapy",
abstract = "Four adult patients with biopsy-proven bronchiolitis were identified and prospectively evaluated. Each patient presented with the rapid onset (weeks to months) of severe respiratory disease that was clinically distinct from asthma, chronic bronchitis, bronchiectasis, cystic fibrosis, and emphysema. Bronchiolitis patients were evaluated by pulmonary function testing and bronchoalveolar lavage (BAL) before and after two months of treatment with 1 mg/kg/day of prednisone. Inital BAL results of bronchiolitis patients were compared to those of cigarette smokers with chronic bronchitis (n=4), asymptomatic cigarette smokers (n=5), and normal nonsmoking volunteers (n=5). Neutrophils comprised 53 ± 13 percent of the cells recovered by BAL in bronchiolitis patients but only 3 ± 2 percent of the cells in chronic bronchitis patients, 1.5 ± 0.6 percent of the cells in asymptomatic smokers, and 0.3 ± 0.3 percent of the cells in normal volunteers (p < 0.01, all comparisons). Moreover, prednisone produced a striking decrease in lower respiratory tract neutrophils (53 ± 13 percent to 8 ± 3 percent, p < 0.05) in all bronchiolitis patients while lung function either improved (two patients) or remained unchanged (two patients). These findings suggest a central role for the neutrophil in bronchiolitis and argue that BAL may be clinically useful in the diagnosis and management of these patients.",
author = "Dorinsky, {P. M.} and Davis, {W. B.} and Lucas, {J. G.} and Weiland, {J. E.} and Gadek, {J. E.}",
year = "1985",
month = "1",
day = "1",
doi = "10.1378/chest.88.1.58",
language = "English (US)",
volume = "88",
pages = "58--63",
journal = "Chest",
issn = "0012-3692",
publisher = "American College of Chest Physicians",
number = "1",

}

TY - JOUR

T1 - Adult bronchiolitis. Evaluation by bronchoalveolar lavage and responses to prednisone therapy

AU - Dorinsky, P. M.

AU - Davis, W. B.

AU - Lucas, J. G.

AU - Weiland, J. E.

AU - Gadek, J. E.

PY - 1985/1/1

Y1 - 1985/1/1

N2 - Four adult patients with biopsy-proven bronchiolitis were identified and prospectively evaluated. Each patient presented with the rapid onset (weeks to months) of severe respiratory disease that was clinically distinct from asthma, chronic bronchitis, bronchiectasis, cystic fibrosis, and emphysema. Bronchiolitis patients were evaluated by pulmonary function testing and bronchoalveolar lavage (BAL) before and after two months of treatment with 1 mg/kg/day of prednisone. Inital BAL results of bronchiolitis patients were compared to those of cigarette smokers with chronic bronchitis (n=4), asymptomatic cigarette smokers (n=5), and normal nonsmoking volunteers (n=5). Neutrophils comprised 53 ± 13 percent of the cells recovered by BAL in bronchiolitis patients but only 3 ± 2 percent of the cells in chronic bronchitis patients, 1.5 ± 0.6 percent of the cells in asymptomatic smokers, and 0.3 ± 0.3 percent of the cells in normal volunteers (p < 0.01, all comparisons). Moreover, prednisone produced a striking decrease in lower respiratory tract neutrophils (53 ± 13 percent to 8 ± 3 percent, p < 0.05) in all bronchiolitis patients while lung function either improved (two patients) or remained unchanged (two patients). These findings suggest a central role for the neutrophil in bronchiolitis and argue that BAL may be clinically useful in the diagnosis and management of these patients.

AB - Four adult patients with biopsy-proven bronchiolitis were identified and prospectively evaluated. Each patient presented with the rapid onset (weeks to months) of severe respiratory disease that was clinically distinct from asthma, chronic bronchitis, bronchiectasis, cystic fibrosis, and emphysema. Bronchiolitis patients were evaluated by pulmonary function testing and bronchoalveolar lavage (BAL) before and after two months of treatment with 1 mg/kg/day of prednisone. Inital BAL results of bronchiolitis patients were compared to those of cigarette smokers with chronic bronchitis (n=4), asymptomatic cigarette smokers (n=5), and normal nonsmoking volunteers (n=5). Neutrophils comprised 53 ± 13 percent of the cells recovered by BAL in bronchiolitis patients but only 3 ± 2 percent of the cells in chronic bronchitis patients, 1.5 ± 0.6 percent of the cells in asymptomatic smokers, and 0.3 ± 0.3 percent of the cells in normal volunteers (p < 0.01, all comparisons). Moreover, prednisone produced a striking decrease in lower respiratory tract neutrophils (53 ± 13 percent to 8 ± 3 percent, p < 0.05) in all bronchiolitis patients while lung function either improved (two patients) or remained unchanged (two patients). These findings suggest a central role for the neutrophil in bronchiolitis and argue that BAL may be clinically useful in the diagnosis and management of these patients.

UR - http://www.scopus.com/inward/record.url?scp=0021802514&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021802514&partnerID=8YFLogxK

U2 - 10.1378/chest.88.1.58

DO - 10.1378/chest.88.1.58

M3 - Article

VL - 88

SP - 58

EP - 63

JO - Chest

JF - Chest

SN - 0012-3692

IS - 1

ER -